Click on headlines below to download research

Sailing a steady course
e-Therapeutics | 04/10/2017

e-Therapeutics’ (ETX) interim numbers demonstrate tight cost control and focus on the rationalised pipeline, with continued investment into the Network-Driven…

Executive interview - e-Therapeutics
Executive interview - e-Therapeutics | 09/08/2017

e-Therapeutics (ETX) is a UK-based drug discovery company that has developed a proprietary, computer-based discovery platform based on network biology.…

Strategic review complete: focus on deal-making
e-Therapeutics | 27/07/2017

New CEO Dr Ray Barlow, who joined e-Therapeutics (ETX) in April, has undertaken a business and strategic review, assisted by an independent industry-wide…